Found: 11
Select item for more details and to access through your institution.
A conserved role of the insulin-like signaling pathway in diet-dependent uric acid pathologies in Drosophila melanogaster.
- Published in:
- PLoS Genetics, 2019, v. 15, n. 8, p. 1, doi. 10.1371/journal.pgen.1008318
- By:
- Publication type:
- Article
Postremission cytopenia management in patients with acute myeloid leukemia treated with venetoclax and azacitidine in VIALE‐A.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E416, doi. 10.1002/ajh.26692
- By:
- Publication type:
- Article
Risk‐Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 112, n. 4, p. 754, doi. 10.1002/cpt.2448
- By:
- Publication type:
- Article
Genome‐Wide Association and Functional Studies Reveal Novel Pharmacological Mechanisms for Allopurinol.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 3, p. 623, doi. 10.1002/cpt.1439
- By:
- Publication type:
- Article
Influence of Transporter Polymorphisms on Drug Disposition and Response: A Perspective From the International Transporter Consortium.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 803, doi. 10.1002/cpt.1098
- By:
- Publication type:
- Article
Reverse Translational Research of <italic>ABCG2</italic> (BCRP) in Human Disease and Drug Response.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 2, p. 233, doi. 10.1002/cpt.903
- By:
- Publication type:
- Article
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 4, p. 743, doi. 10.1002/hon.3159
- By:
- Publication type:
- Article
Venetoclax exposure‐efficacy and exposure‐safety relationships in patients with treatment‐naïve acute myeloid leukemia who are ineligible for intensive chemotherapy.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 2, p. 269, doi. 10.1002/hon.2964
- By:
- Publication type:
- Article
Impact of Multiple Concomitant CYP3A Inhibitors on Venetoclax Pharmacokinetics: A PBPK and Population PK‐Informed Analysis.
- Published in:
- Journal of Clinical Pharmacology, 2023, v. 63, n. 1, p. 119, doi. 10.1002/jcph.2140
- By:
- Publication type:
- Article
Oxypurinol pharmacokinetics and pharmacodynamics in healthy volunteers: Influence of BCRP Q141K polymorphism and patient characteristics.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 4, p. 1431, doi. 10.1111/cts.12992
- By:
- Publication type:
- Article
Liposomal resiquimod for the treatment of Leishmania donovani infection.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 1, p. 168, doi. 10.1093/jac/dkt320
- By:
- Publication type:
- Article